27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
In a report published Wednesday, D.A. Davidson analyst Tim Ramey reiterated a Neutral rating on USANA Health Sciences (NYSE: USNA), and raised the price target from $80.00 to $92.00.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
In the report, D.A. Davidson noted, “Q2 operating EPS of $1.72 was up ~55% from $1.11 last year, exceeding our $1.23 estimate and the 5-analyst Street mean of $1.33. Results were driven by sales increases in the Asia Pacific and North America/Europe segments, as well as a $1.2 million benefit from favorable exchange rates. The tax rate of 33.4% was 40bp higher than our forecast. Net sales of $189.1 million increased 17.5% year-over-year. On a segment basis, sales in North America grew 6.9%, SE Asia/Pacific was up 9.3%, China increased 36.3%, and North Asia climbed 1.5%. Total Active Associates' growth was 8.1%, led by Greater China, which grew 18.4%. North Asia was the second fastest growing segment, up 12.5%. Active Associates in SE Asia/Pacific grew 3.4%, while North America was flat.”
USANA Health Sciences closed on Tuesday at $80.55.